(Q38241121)

31 August 2017

MicroRNAs: a new key in lung cancer (English)

1 reference

31 August 2017

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25135624%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Yunlong Zhang

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25135624%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Qian Yang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25135624%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

publication date

19 August 2014

1 reference

Cancer Chemotherapy and Pharmacology

31 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25135624%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25135624%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25135624%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

1105-1111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25135624%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00280-014-2559-9

4 June 2020

exact match

0 references

cites work

Autophagy inhibition promotes 5-fluorouraci-induced apoptosis by stimulating ROS formation in human non-small cell lung cancer A549 cells

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

Predicting US- and state-level cancer counts for the current calendar year: Part I: evaluation of temporal projection methods for mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

The microRNA miR-196 acts upstream of Hoxb8 and Shh in limb development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

The functions of animal microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

Origins and Mechanisms of miRNAs and siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

MicroRNA: Biogenesis, Function and Role in Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

PIASx is a transcriptional co-repressor of signal transducer and activator of transcription 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

miR-15 and miR-16 induce apoptosis by targeting BCL2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

MicroRNAs and other non-coding RNAs as targets for anticancer drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

let-7 and miR-17-92: small-sized major players in lung cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

MicroRNA expression differentiates histology and predicts survival of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

miR-205 Expression levels in nonsmall cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

Plasma microRNAs as potential biomarkers for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

miRNAs in lung cancer - studying complex fingerprints in patient's blood cells by microarray experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

Dysregulation of microRNAs in cancer: playing with fire

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

MicroRNA expression differentiates between primary lung tumors and metastases to the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

MicroRNA 92a-2*: a biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

Prognostic significance of serum microRNA-210 levels in nonsmall-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

Novel strategies for the treatment of small-cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

Targeted therapies for lung cancer: clinical experience and novel agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

LIN28B confers radio-resistance through the posttranscriptional control of KRAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

microRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

Radiosensitizing effects of ectopic miR-101 on non-small-cell lung cancer cells depend on the endogenous miR-101 level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

Alterations of microRNAs in cisplatin-resistant human non-small cell lung cancer cells (A549/DDP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

miR-181a and miR-630 regulate cisplatin-induced cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

MicroRNA-31 inhibits cisplatin-induced apoptosis in non-small cell lung cancer cells by regulating the drug transporter ABCB9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

MicroRNA-650 was a prognostic factor in human lung adenocarcinoma and confers the docetaxel chemoresistance of lung adenocarcinoma cells via regulating Bcl-2/Bax expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9

RNAi therapeutics and applications of microRNAs in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2559-9